Novelion Therapeutics Reports First Quarter 2017 Financial Results

Go back to Novelion Therapeutics Reports First Quarter 2017 Financial Results
(NASDAQ: NVLN) Delayed: 0.68 --0 (-0%)
Previous Close $0.68    52 Week High
Open $0.01    52 Week Low
Day High $0.68    P/E N/A 
Day Low $0.68    EPS
Volume 408,294